Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving cytoreductive medications? a retrospective analysis of real-world data. Exp Hematol Oncol. 2018, 7:16. doi: 10.1186/s40164-018-0107-8.
Advertisement
Articles by Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving cytoreductive medications? a retrospective analysis of real-world data. Exp Hematol Oncol. 2018, 7:16. doi: 10.1186/s40164-018-0107-8.
Advertisement
Latest Updated Articles
- Study Summary: Real-World Adherence to Cytoreductive Treatment in Polycythemia Vera Is Low
Published: August 28th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
2
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD
5
